SPTBN2-FGF19 Fusion FISH Probe
The SPTBN2-FGF19 Fusion FISH Probe is used to confirm a fusion of the SPTBN2 and FGF19 genes. The fusion of the SPTBN2 and FGF19 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SPTBN2-FGF19-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SPTBN2-FGF19-20-AQAQ | 20 (40 μL) | 200 μL |
|
SPTBN2 Gene Summary
Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]
Gene Name: Spectrin Beta, Non-erythrocytic 2
Chromosome: CHR11: 66452719 -66488870
Locus: 11q13.2
FGF19 Gene Summary
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes including embryonic development cell growth, morphogenesis, tissue repair, tumor growth and invasion. This growth factor is a high affinity, heparin dependent ligand for FGFR4. Expression of this gene was detected only in fetal but not adult brain tissue. Synergistic interaction of the chick homolog and Wnt-8c has been shown to be required for initiation of inner ear development. [provided by RefSeq, Jul 2008]
Gene Name: Fibroblast Growth Factor 19
Chromosome: CHR11: 69513005 -69519106
Locus: 11q13.3
Gene Diseases
The SPTBN2 FGF19 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|